位置:首页 > 蛋白库 > PAXI1_BOVIN
PAXI1_BOVIN
ID   PAXI1_BOVIN             Reviewed;         984 AA.
AC   A0JNA8;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 1.
DT   03-AUG-2022, entry version 92.
DE   RecName: Full=PAX-interacting protein 1;
DE   AltName: Full=PAX transactivation activation domain-interacting protein;
GN   Name=PAXIP1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Fetal liver;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in DNA damage response and in transcriptional
CC       regulation through histone methyltransferase (HMT) complexes. Plays a
CC       role in early development. In DNA damage response is required for cell
CC       survival after ionizing radiation. In vitro shown to be involved in the
CC       homologous recombination mechanism for the repair of double-strand
CC       breaks (DSBs). Its localization to DNA damage foci requires RNF8 and
CC       UBE2N. Recruits TP53BP1 to DNA damage foci and, at least in particular
CC       repair processes, effective DNA damage response appears to require the
CC       association with TP53BP1 phosphorylated by ATM at 'Ser-25'. Together
CC       with TP53BP1 regulates ATM association. Proposed to recruit PAGR1 to
CC       sites of DNA damage and the PAGR1:PAXIP1 complex is required for cell
CC       survival in response to DNA damage; the function is probably
CC       independent of MLL-containing histone methyltransferase (HMT)
CC       complexes. However, this function has been questioned (By similarity).
CC       Promotes ubiquitination of PCNA following UV irradiation and may
CC       regulate recruitment of polymerase eta and RAD51 to chromatin after DNA
CC       damage. Proposed to be involved in transcriptional regulation by
CC       linking MLL-containing histone methyltransferase (HMT) complexes to
CC       gene promoters by interacting with promoter-bound transcription factors
CC       such as PAX2. Associates with gene promoters that are known to be
CC       regulated by KMT2D/MLL2. During immunoglobulin class switching in
CC       activated B-cells is involved in trimethylation of histone H3 at 'Lys-
CC       4' and in transcription initiation of downstream switch regions at the
CC       immunoglobulin heavy-chain (Igh) locus; this function appears to
CC       involve the recruitment of MLL-containing HMT complexes. Conflictingly,
CC       its function in transcriptional regulation during immunoglobulin class
CC       switching is reported to be independent of the MLL2/MLL3 complex (By
CC       similarity). {ECO:0000250|UniProtKB:Q6NZQ4,
CC       ECO:0000250|UniProtKB:Q6ZW49}.
CC   -!- SUBUNIT: Interacts with the C-terminal transactivation domain of PAX2
CC       (By similarity). Forms a constitutive complex with PAGR1 independently
CC       of the MLL2/MLL3 complex. Interacts with TP53BP1 (when phosphorylated
CC       at the N-terminus by ATM). Interacts with HLTF. Component of the KMT2
CC       family MLL2/MLL3 complex (also named ASCOM complex), at least composed
CC       of the HMTs KMT2D and/or KMT2C, the common subunits ASH2L, RBBP5, WDR5
CC       and DPY30, and the complex type-specific subunits PAXIP1/PTIP, PAGR1,
CC       NCOA6 and KDM6A; required for the association of PAGR1 with the
CC       MLL2/MLL3 complex (By similarity). Interacts with NUPR1; this
CC       interaction prevents PAXIP1 inhibition of PAX2 transcription factor
CC       activity (By similarity). {ECO:0000250|UniProtKB:Q6NZQ4,
CC       ECO:0000250|UniProtKB:Q6ZW49}.
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000250|UniProtKB:Q6NZQ4}.
CC       Chromosome {ECO:0000250|UniProtKB:Q6ZW49}. Note=Localizes to DNA damage
CC       foci upon ionizing radiation. {ECO:0000250|UniProtKB:Q6ZW49}.
CC   -!- DOMAIN: The BRCT 1 and 2 domains mediate the interaction with PAGR1A.
CC       {ECO:0000250|UniProtKB:Q6NZQ4}.
CC   -!- DOMAIN: The BRCT 5 and 6 domains mediate the association with the
CC       MLL2/MLL3 complex (By similarity). The BRCT 5 and 6 domains function as
CC       a single module and are necessary and sufficient for in vitro phospho-
CC       specific binding (substrates phosphorylated by the kinases ataxia
CC       telangiectasia-mutated (ATM), ataxia telangiectasia and RAD3-related
CC       (ATR) in response to gamma irradiation). In contrast, in vivo two pairs
CC       of BRCT domains (3-6) bind to phosphorylated TP53BP1 much more
CC       efficiently. {ECO:0000250|UniProtKB:Q6NZQ4}.
CC   -!- CAUTION: The terminology of MLL proteins in mammalia is not consistent
CC       also concerning the terminology of MLL protein-containing complexes.
CC       The decribed MLL2/MLL3 complex is commonly described as MLL3/MLL4
CC       complex in literature. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC126589; AAI26590.1; -; mRNA.
DR   RefSeq; NP_001071385.1; NM_001077917.1.
DR   AlphaFoldDB; A0JNA8; -.
DR   SMR; A0JNA8; -.
DR   STRING; 9913.ENSBTAP00000055051; -.
DR   PaxDb; A0JNA8; -.
DR   PRIDE; A0JNA8; -.
DR   Ensembl; ENSBTAT00000023287; ENSBTAP00000023287; ENSBTAG00000017505.
DR   GeneID; 513213; -.
DR   KEGG; bta:513213; -.
DR   CTD; 22976; -.
DR   VEuPathDB; HostDB:ENSBTAG00000017505; -.
DR   VGNC; VGNC:32602; PAXIP1.
DR   eggNOG; KOG2043; Eukaryota.
DR   GeneTree; ENSGT00940000155757; -.
DR   HOGENOM; CLU_009382_0_0_1; -.
DR   InParanoid; A0JNA8; -.
DR   OrthoDB; 840249at2759; -.
DR   Proteomes; UP000009136; Chromosome 4.
DR   Bgee; ENSBTAG00000017505; Expressed in oocyte and 104 other tissues.
DR   ExpressionAtlas; A0JNA8; baseline and differential.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0044666; C:MLL3/4 complex; IBA:GO_Central.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IBA:GO_Central.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IBA:GO_Central.
DR   Gene3D; 3.40.50.10190; -; 5.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR037886; Paxip1.
DR   PANTHER; PTHR23196:SF31; PTHR23196:SF31; 2.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF12738; PTCB-BRCT; 2.
DR   Pfam; PF16770; RTT107_BRCT_5; 1.
DR   SMART; SM00292; BRCT; 6.
DR   SUPFAM; SSF52113; SSF52113; 5.
DR   PROSITE; PS50172; BRCT; 5.
PE   2: Evidence at transcript level;
KW   Chromosome; DNA damage; DNA recombination; DNA repair; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..984
FT                   /note="PAX-interacting protein 1"
FT                   /id="PRO_0000296261"
FT   DOMAIN          8..93
FT                   /note="BRCT 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          94..183
FT                   /note="BRCT 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          516..609
FT                   /note="BRCT 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          616..704
FT                   /note="BRCT 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          781..862
FT                   /note="BRCT 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          883..924
FT                   /note="BRCT 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   REGION          94..183
FT                   /note="Interaction with PAGR1"
FT                   /evidence="ECO:0000250"
FT   REGION          187..271
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          417..509
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          505..984
FT                   /note="Interaction with TP53BP1"
FT                   /evidence="ECO:0000250"
FT   REGION          750..771
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           583..600
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        189..205
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..236
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..258
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        422..453
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        454..481
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..504
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NZQ4"
FT   MOD_RES         235
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZW49"
SQ   SEQUENCE   984 AA;  109167 MW;  2ECFB31F6F7A2A7E CRC64;
     MSGQVPRVPE EMFKEVKYYA VGDLDPQVIQ LLKAGKAKEV SYNALASHII SEDGDNPEVG
     EAREVFDLPV VKPSWVILSV QCGALLPVNG FSPESCQIFF GITACLSQVS PEDRSALWAM
     LTFHGGGCQL NLNRKCTHLV VPEPKGEKYE CALRRASIKI VTPDWVLDCI SEKTRKDEAL
     YHPRLIVYEE EEEEEEEEEG AGNEEPDSPN EGSTDGKSSP ASSQEGSPSG EPPFSPKSSA
     EKSKGELMFD DSSDSSPEKQ ERNLNWTPAE VPQLAAAKRR LPPGKEPGLI NLCANVPPVP
     GGILPPEVRG SLLAPGQSLQ GPERPEVMAA WSPAMRTLRN ITNNADIQQM SSRPSNVAHI
     LQSLSAPTKT LEQQVNHSQQ GPASAVLLGQ VKVAPEPAPA PQPILHLQPQ QLLQLQQQHL
     AQQPYPPPPP HPFPPPPAHP HQFPQPPLQR PQPPLQQQQL SHLQQQQLQH LQRLQQMQPT
     PTAQLPGPPA QALQPPPPQA QAQPPLFGHD PAVEIPEEGF LLGCVFAIAD YPEQMSDKQL
     LATWKRIIQA HGGAVDPTFS SRCTHLLCES QVSGLFAQAM KERKRCITAH WLNTVLKKKK
     LVPPHRALHF PVAFPPGGKP CSQHIISVTG FVDNDRDDLK LMAYLAGAKY TGYLCRSNTV
     LICREPTGLK YEKAKEWRIP CVNAQWLGDI LLGNFEALRQ TQYGRYTAFG LQDPFAPTPQ
     LVLSLLDAWR VPLKVSSELL MGVRLPPKPK QNEVTNVQPS SKRARIEDIP PPTKKLTPEL
     TPFVLFTGFE PVQVQQYIKK LYILGGEVAE SAQKCTHLIA SKVTRTVKFL TAISVVKHIV
     TPEWLEECFK CQKFVDEQNY LLRDAEAEVL FSFSLEESLR RAHASPLFKA KYFYITPGIC
     PSLSTMKAIV ECAGGKVLSR QPSFRKLMEH KQNKSLSEIV LISCENDLHL CREYFARGID
     VHNAEFVLTG VLTQTLDYES YKFN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024